Non-traditional antibodies: Anti-phosphatidylserine/prothrombin antibodies (aPS/PT) have been shown to significantly correlate with LA positivity, thrombosis risk and classification of APS patients. The gene discussed is F2; the disease is autoimmune polyendocrinopathy.